RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 ASCOT-LLA: Statin Legacy Felt with Reduced Non-CV Death Eight Years after Trial End?
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 10
SP 22
OP 23
DO 10.1177/155989771110013
UL http://mdc.sagepub.com/content/11/10/22.abstract
AB Prior treatment with atorvastatin is associated with a reduction in the risk of all-cause mortality compared with placebo 8 years after the early termination of the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm [ASCOT-LLA] and 11 years after initial randomization, according to new findings from a long-term follow-up study.